Level of LncRNA GAS5 and Hippocampal Volume are Associated with the Progression of Alzheimer's Disease
Xiaopeng Chen,Guoqiang Ren,Yan Li,Wa Chao,Siyuan Chen,Xuezhong Li,Shouru Xue
DOI: https://doi.org/10.2147/cia.s363116
IF: 3.829
2022-05-10
Clinical Interventions in Aging
Abstract:Xiaopeng Chen, 1, 2 Guoqiang Ren, 3 Yan Li, 1, 4 Wa Chao, 1 Siyuan Chen, 2 Xuezhong Li, 2 Shouru Xue 1 1 Department of Neurology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China; 2 Department of Neurology, the Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China; 3 Department of Radiology, the Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China; 4 Department of Neurology, the Taixing People's Hospital, Taixing, Jiangsu, People's Republic of China Correspondence: Shouru Xue, Department of Neurology, the First Affiliated Hospital of Soochow University, No. 188 Shizi Road, Suzhou, Jiangsu Province, 215006, People's Republic of China, Tel +86-18962133036, Fax +86-512-65223637, Email Purpose: We evaluated the diagnostic value of long non-coding RNA growth arrest-specific transcript 5 (GAS5) and its relationship with hippocampal volume in Alzheimer's disease (AD). Patients and Methods: One hundred and eight patients with AD and 83 healthy controls were included, and demographic data, biochemical parameters, GAS5 levels, and hippocampal volume were recorded. Chi-squared tests or independent sample t-tests were used to compare the baseline characteristics, relative expression of GAS5, and hippocampal volume. Correlations between variables were determined using Spearman's rank correlation test. Receiver operating characteristic (ROC) curves were generated to compare the diagnostic value of GAS5 and total hippocampal volume in AD. Results: The levels of GAS5 were significantly upregulated in patients with AD compared with those in controls and were negatively correlated with MMSE score. There were differences in left hippocampal volume, right hippocampal volume, and total hippocampal volume between the two groups. Total hippocampal volume was positively correlated with MMSE score and negatively correlated with GAS5 expression in patients with AD. The area under the curve (AUC) of for GAS5 expression was 0.831, the sensitivity was 61.1%, and the specificity was 95.2%. The AUC of the combined total hippocampal volume was 0.891, the sensitivity was 74.1%, and the specificity was 92.8%. Conclusion: The results suggested that GAS5 may be an excellent indicator of AD progression alone or in combination with hippocampal volume. Keywords: Alzheimer's disease, long non-coding RNA, receiver operating characteristic, biomarker Alzheimer's disease (AD) is the main cause of dementia, accounting for 60%–80% of all cases. Alzheimer's disease is a neurodegenerative disease characterized by progressive memory loss, cognitive impairment, and behavioral changes. 1 Pathological changes in AD include reduced brain volume, with particularly severe loss of volume in the hippocampus. 2 The prevalence of AD is increasing in parallel with an increasingly aging global population. An estimated 6.2 million Americans aged 65 and over had AD, and 72% were 75 years old or older in 2021. 3 By 2050, the prevalence of AD in Germany will double. 4 A cross-sectional study in 2020 showed that 15.07 million people aged 60 and over in China had dementia, including 9.83 million with AD. 5 Alzheimer's disease is rapidly becoming one of the most expensive and deadly diseases in the world. 6 Development of diagnostic criteria for AD has been a challenge due to the mismatch between clinical manifestations and pathology. 7 Blood tests have been developed recently to reduce the use of lumbar puncture and PET scanning, which are uncomfortable and expensive, respectively. Many of these blood tests are currently in the process of being validated after which they can be used for diagnostic purposes in clinical practice. 8 In the past 20 years, sequencing and analysis of human and mouse genomes has led to the discovery of many non-coding RNAs (ncRNAs), including microRNAs (miRNAs), small interfering RNAs (siRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs). Using chromatin immunoprecipitation, studies have shown that a variety of lncRNA are specifically expressed in brain tissue and participate in the regulation of many important neural functions, such as brain tissue aging, hippocampal development, oligodendrocyte myelin synthesis, synaptic transmission, and signal transduction. 9 Long non-coding RNAs have great potential as AD biomarkers and as therapeutic targets. 10 Long non-coding RNA growth arrest-specific transcript 5 (GAS5) is a lncRNA reported to have multiple regulatory functions. 11</ -Abstract Truncated-
geriatrics & gerontology,gerontology